Menu
Request a demo

Our products

An agile launch execution platform, with full visibility across countries and functions.
A collaborative platform for teams who plan reimbursements and HTA activities.
A collaborative platform designed to manage pharmaceutical tenders across countries.
A capability management platform that unifies capabilities, resources, and assessment.
Manage your entire pipeline. Track every move. Stay ahead, from discovery to launch.

Our expertise

Launch Readiness

Market Access

Tender Management

Featured Post

6 Pharma Trends for 2025: Trump’s Return, AI Breakthroughs, and Market Access Challenges

  • Andre Moa
  • 21 Jan 2025
  • 21 minute read

Pharma is facing a new set of launch, market access and strategic challenges as the pandemic has changed some market characteristics for good.

Read more

Latest posts

6 Pharma Trends for 2025: Trump’s Return, AI Breakthroughs, and Market Access Challenges

Discover 6 key pharma trends for 2025, including Trump's policies, AI-driven innovations, market access challenges, and evolving global regulations shaping the industry.

Read more

Market Access 2025: Navigating the emerging HTA and drug reimbursement challenges

Discover insights from 'Market Access 2025' on overcoming HTA and drug reimbursement challenges. Learn strategies to navigate evolving market access hurdles.

Read more

Market Access 2023: New Report on key challenges in HTA and reimbursement

As market access barriers proliferate, digitally enabled alignment is key to optimising new drug uptake.

Read more

How the coronavirus crisis could affect your new drug launch

The coronavirus is forcing pharma to think creatively about remote working in a constrained environment. Digital technology will be crucial in softening the pandemic’s multiple impacts on drug launches.

Read more

From Volume to Value: Strategising launch readiness in 2020

The pharmaceutical market in 2020 is more about product diversity, breakthrough science and new therapeutic targets than spectacular launch volumes.

Read more

5 Pharma Trends for 2020: Counting the value and cost of innovation

The pharmaceutical market in 2020 is more about product diversity, breakthrough science and new therapeutic targets than spectacular launch volumes.

Read more

6 pharma trends for 2019 that will set the pace for industry

We take a look at the Top 6 Pharma Trends for 2019: From slowing sales growth, biosimilars getting serious, growing pressure on US pricing, more Brexit uncertainty, value focused R&D to the need to address the industry’s ‘me-too’ deficit.

Read more

The Essential Tender Management Checklist for Pharma

The right tender management tools will help pharmaceutical and biotechnology companies overcome the market access challenges of a growing but complex tenders sector.

Read more

Resolving the new market access challenges created by tenders

The right digital management tools will help pharmaceutical companies overcome the market access challenges of a growing but complex tenders sector.

Read more

6 Pharma Trends for 2018 [INFOGRAPHIC]

6 of our key pharma trends that will shape the industry are illustrated on our pharma trends for 2018 infographic.

Read more

6 pharma trends for 2018 that will shape the industry

Value, innovation, inter-connectivity, personalisation, and the disruptive impact of digital tools and online retail: these are key pharma trends for 2018.

Read more

5 ways our launch and market access tools will save you time

A smart business tool can save you time to optimise efficiency and market access in a pharma sector swamped with data, communications and multiple inputs.

Read more

Recent Posts

Most Popular Posts

Categories

Get our latest
posts in your inbox

TRiBECA Knowledge needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Notice.